Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
Clinical trial NCT02715505 · WITHDRAWN
Trial details
- NCT number
- NCT02715505
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2020-05-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.